Skip to main content
USNA logo

USNA · Usana Health Sciences Inc

$14.66 -0.33 (-2.20%)
Market Cap
$276.76M
Shares
18.46M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$14.99 Open$18.24 Day$14.48–18.24 52W$14.48–32.32 Avg vol 30d121K Short int753K · 4.1% float · 8.6d Short vol68% Last earningsAug 5, 2026 DataJan 2020–Aug 2026 Filing10-Q · May 12

Up next

Next earnings call
Oct 29, 2026 Est · unconfirmed · in 12 wks
FQ3-27 quarter ends
~Oct 3, 2026 Est
filed May 12, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 15.8 · calm Equity put/call 0.46
      Technical
      price trend
      Strong Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −24%
      below
      Price vs 50-day avg −27%
      below
      RSI (14) 27
      oversold
      MACD trend Negative
      52-week position 3%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Weak
      1-month return −29%
      trailing
      6-month return −29%
      trailing
      YTD return −24%
      this year
      Relative strength −40%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $20 › 200d $20 — 50d above 200d
      Institutional flow Accumulating
      34 of 138 funds reported for Jun 30 · net +13.8K sh shares · +8 new
      Insider flow Distributing
      Net -$543.9K over 90 days · 100% sells
      Short interest Rising
      4.08% of float · ▲ +14.1% MoM · 8.6 days cover
      Volume signal Reversal watch
      High volume on a down day — possible exhaustion
      Institution breadth Steady
      138 holders — mid 3-yr range
      Squeeze score 70
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth −11%
      Y/Y
      Gross margin 68%
      expanding
      EPS growth −74%
      Y/Y
      Free cash flow $8.5M
      Valuation P/E 30
      in line
      Buyback $34.0M
      remaining
      Balance sheet $158.4M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 57%
      annualized · 1-yr
      Max drawdown −54%
      past year
      ATR 9.8%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed May 5, 2026
      Hiya net sales · fiscal year 2026 Initiated $140M – $155M
      Rise Wellness net sales · fiscal year 2026 Initiated $65M – $80M
      Consolidated net sales · fiscal year 2026 Maintained $925M – $1B
      prior FY $925.26M midpoint +4.0% Y/Y
      Net earnings · fiscal year 2026 Initiated $20M – $27M
      Guided vs delivered · last 1 settled
      Net sales for HIA full year 2026
      guided $140M – $155M
      $925.26M Beat +527.3%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Sell
      4 · 3 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −24% Bearish
      Price vs 50-day avg
      −27% Bearish
      RSI (14)
      27 Neutral
      MACD trend
      Negative Bearish
      52-week position
      3% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $20 › 200d $20 — 50d above 200d
      Institutional flow Accumulating
      34 of 138 funds reported for Jun 30 · net +13.8K sh shares · +8 new
      Insider flow Distributing
      Net -$543.9K over 90 days · 100% sells
      Short interest Rising
      4.08% of float · ▲ +14.1% MoM · 8.6 days cover
      Volume signal Reversal watch
      High volume on a down day — possible exhaustion
      Institution breadth Steady
      138 holders — mid 3-yr range
      Price context
      position in its 52-week range
      52-wk low $14 Now $15 · 3% 52-wk high $32
      vs 200-day avg -24% vs 50-day avg -27%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      Adjusted diluted EPS non-GAAP -$0.07 Q2 2026
      Free cash flow $20M Q2 2026
      USANA Active Customers 387,000 FY 2025

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      Packaged Foods — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      USNA
      Usana Health Sciences Inc
      this stock
      $276.76M -23.6% -10.8% 30.0 4.1%
      JBS
      Jbs N.V.
      $45.06B +2.6% 1.0%
      KHC
      Kraft Heinz Co
      $30.51B +9.8% +0.6% 7.8%
      GIS
      General Mills Inc
      $19.18B -18.9% +4.1% 10.2%
      MKC
      Mccormick & Co Inc
      $14.13B -21.5% +1.7% 8.7 5.7%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      141
      % held
      54.0%
      Reported
      34 of 138
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      166
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      753.0K
      Days to cover
      8.6d
      Change
      +93.3K sh
      View
      Short Volume
      Short vol %
      68%
      As of
      Aug 5, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      5.8K
      Value
      $122.2K
      As of
      Jun 30, 2026
      View
      Off-Exchange
      Off-exchange %
      35.1%
      Week of
      Jun 29, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$543.9K
      Buyers / Sellers
      0 / 5
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $925.3M
      Net income (FY)
      $10.8M
      EPS diluted
      $0.58
      View
      Buybacks
      Authorized
      $150.0M
      Remaining
      $34.0M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 4, 2026
      This year
      10
      View
      Proposed Sales
      Value
      $97.3K
      Shares
      5.0K
      Filed
      Jun 16, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 5, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      USNA -33.9% -29.2% -29.1% -32.2% -23.6%
      SPY +5.5% +3.3% +11.3% +3.1% +12.9%
      vs SPY -39.4% -32.5% -40.3% -35.3% -36.5%

      Capital returns

      Buyback program · as of Aug 4, 2026
      Authorized
      $150.00M
      Spent (derived)
      $116.00M
      Remaining
      $34.00M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 896264 CUSIP 90328M107 13F (30d) 28 filings 28 filers Visit website Investor relations